Mishra Vinayak, Cuna Alain, Singh Rachana, Schwartz Daniel M, Chan Sherwin, Maheshwari Akhil
Department of Pediatrics, Grant Medical College and Sir JJ Group of Hospitals, Mumbai, Maharashtra, India.
Division of Neonatology, Children's Mercy, Kansas City, Missouri, United States of America.
Newborn (Clarksville). 2022 Jan-Mar;1(1):182-189. doi: 10.5005/jp-journals-11002-0002. Epub 2022 Mar 31.
Necrotizing enterocolitis (NEC) is inflammatory bowel necrosis of preterm and critically ill infants. The disease is seen in 6-10% of preterm infants who weigh less than 1500 g at birth and carries considerable morbidity, mortality, and healthcare cost burden. Efforts focused on timely mitigation remain restricted due to challenges in early diagnosis as clinical features, and available laboratory tests remain nonspecific until late in the disease. There is renewed interest in the radiological and sonographic assessment of intestinal diseases due to technological advances making them safe, cost-efficient, and supporting Web-based transmission of images, thereby reducing time to diagnosis by disease experts. Most of our experience has been with plain abdominal radiography, which shows characteristic features such as pneumatosis intestinalis in up to 50-60% of patients. Many patients with advanced disease may also show features such as portal venous gas and pneumoperitoneum. Unfortunately, these features are not seen consistently in patients with early, treatable conditions, and hence, there has been an unfulfilled need for additional imaging modalities. In recent years, abdominal ultrasound (AUS) has emerged as a readily available, noninvasive imaging tool that may be a valuable adjunct to plain radiographs for evaluating NEC. AUS can allow real-time assessment of vascular perfusion, bowel wall thickness, with higher sensitivity in detecting pneumatosis, altered peristalsis, and characteristics of the peritoneal fluid. Several other modalities, such as contrast-enhanced ultrasound (CEUS), magnetic resonance imaging (MRI), and near-infrared spectroscopy (NIRS), are also emerging. In this article, we have reviewed the available imaging options for NEC evaluation.
坏死性小肠结肠炎(NEC)是早产和危重症婴儿的炎症性肠坏死。该疾病在出生时体重小于1500g的早产婴儿中发病率为6%-10%,会带来相当大的发病率、死亡率及医疗费用负担。由于早期诊断存在挑战,因为临床特征以及现有的实验室检查在疾病晚期之前仍不具有特异性,所以专注于及时缓解的努力仍然受限。由于技术进步使放射学和超声检查对肠道疾病的评估变得安全、经济高效且支持基于网络的图像传输,从而减少了疾病专家的诊断时间,因此人们对其重新产生了兴趣。我们的大部分经验来自于腹部平片,其在高达50%-60%的患者中显示出诸如肠壁积气等特征性表现。许多晚期疾病患者还可能表现出门静脉积气和气腹等特征。不幸的是,这些特征在早期可治疗的患者中并非始终可见,因此,对其他成像方式一直存在未满足的需求。近年来,腹部超声(AUS)已成为一种易于获得的非侵入性成像工具,在评估NEC时可能是腹部平片的有价值辅助手段。AUS可以实时评估血管灌注、肠壁厚度,在检测肠壁积气、蠕动改变和腹腔积液特征方面具有更高的敏感性。其他几种方式,如超声造影(CEUS)、磁共振成像(MRI)和近红外光谱(NIRS)也正在兴起。在本文中,我们回顾了用于NEC评估的现有成像选择。